Early estimation of acute myocardial infarct size soon after coronary reperfusion using emission computed tomography with technetium-99m pyrophosphate
- PMID: 2823591
- DOI: 10.1016/0002-9149(87)90331-6
Early estimation of acute myocardial infarct size soon after coronary reperfusion using emission computed tomography with technetium-99m pyrophosphate
Abstract
Early appearance of positive findings on a technetium-99m pyrophosphate scan has been shown to be associated with the presence of a reperfused acute myocardial infarction (AMI). Early technetium-99m pyrophosphate imaging was performed by emission computed tomography to evaluate reperfusion and to test the feasibility of estimating infarct size soon after coronary reperfusion based on acute positive tomographic findings. Twenty-seven patients with transmural AMI who were treated with intracoronary urokinase infusion followed by percutaneous transluminal coronary angioplasty underwent pyrophosphate imaging 8.7 +/- 2.1 hours after the onset of AMI. None of the 8 patients in whom reperfusion was unsuccessful had acute positive findings. Of 19 patients in whom reperfusion was successful, 17 had acute positive findings (p less than 0.001). In these 17, tomographic infarct volumes were determined from reconstructed transaxial images. The threshold for areas of increased pyrophosphate uptake within the infarct was set at 60% of peak activity by the computerized edge-detection algorithm. The total number of pixels in all transaxial sections showing increased tracer uptake were added and multiplied by a size factor and 1.05 g/cm3 muscle to determine infarct volume. The correlations of tomographic infarct volumes with peak serum creatine kinase (CK) levels (r = 0.82) and with cumulative release of CK-MB isoenzyme (r = 0.89) were good. Moreover, the time to positive imaging was significantly shorter than that to peak CK level (8.5 +/- 2.3 vs 10.4 +/- 2.2 hours, p less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].J Cardiol. 1987 Jun;17(2):231-9. J Cardiol. 1987. PMID: 2966242 Japanese.
-
Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.Am J Cardiol. 1985 Aug 1;56(4):252-6. doi: 10.1016/0002-9149(85)90844-6. Am J Cardiol. 1985. PMID: 4025161
-
Emission computed tomography with technetium-99m pyrophosphate for delineating location and size of acute myocardial infarction in man.Br Heart J. 1984 Jul;52(1):30-7. doi: 10.1136/hrt.52.1.30. Br Heart J. 1984. PMID: 6331479 Free PMC article.
-
[Scintigraphic findings in myocardial infarct].Radiologe. 1988 Sep;28(9):409-16. Radiologe. 1988. PMID: 2847229 Review. German.
-
Role of cardiovascular nuclear medicine in evaluating trauma and the postoperative patient.Semin Nucl Med. 1983 Apr;13(2):123-41. doi: 10.1016/s0001-2998(83)80005-1. Semin Nucl Med. 1983. PMID: 6306831 Review.
Cited by
-
Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging.World J Radiol. 2010 Jan 28;2(1):1-14. doi: 10.4329/wjr.v2.i1.1. World J Radiol. 2010. PMID: 21160735 Free PMC article.
-
Admission ECG changes predict short term-mortality after acute myocardial infarction less reliable in patients with diabetes.Sci Rep. 2021 Mar 18;11(1):6307. doi: 10.1038/s41598-021-85674-9. Sci Rep. 2021. PMID: 33737645 Free PMC article.
-
Infarct sizing by scintigraphic techniques and nuclear magnetic resonance imaging.Eur J Nucl Med. 1990;17(1-2):83-90. doi: 10.1007/BF00819409. Eur J Nucl Med. 1990. PMID: 2083547 Review.
-
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.Trials. 2013 May 2;14:123. doi: 10.1186/1745-6215-14-123. Trials. 2013. PMID: 23782531 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous